| Literature DB >> 29179519 |
Hong-Jie Li1, Bao-Liang Zhong1, Yan-Min Xu1, Jun-Hong Zhu1, Jin Lu2.
Abstract
Given the socially isolated status of Chinese heroin-dependent patients (HDPs) and the significant association between loneliness and sleep problem in the general population, the impact of loneliness on sleep of HDPs is potentially substantial. The study aimed to test whether loneliness is associated with poor sleep in terms of quantity and quality in a consecutive sample of Chinese HDPs receiving methadone maintenance treatment (MMT). The study participants were 603 HDPs of three MMT clinics in Wuhan, China. Data on socio-demographic and clinical characteristics were collected by a standardized self-administered questionnaire. Sleep outcomes included sleep latency, sleep duration, sleep efficiency, and sleep quality. We measured depressive symptoms, loneliness, and sleep quality by using Zung's Self-rating Depression Scale, the single-item self-report of loneliness, and the Pittsburgh Sleep Quality Index, respectively. Multiple linear regression was used to examine whether loneliness is independently associated with sleep measures. After controlling for the confounding effects of potential socio-demographic and clinical variables, loneliness was significantly associated with longer sleep latency, shorter sleep duration, lower sleep efficiency, and poorer sleep quality. Loneliness may exacerbate sleep disturbance in Chinese HDPs of MMT clinics. Psychosocial interventions aimed at reducing loneliness in MMT clinics would improve the sleep of HDPs.Entities:
Keywords: heroin dependence; loneliness; methadone; sleep
Year: 2017 PMID: 29179519 PMCID: PMC5687689 DOI: 10.18632/oncotarget.20061
Source DB: PubMed Journal: Oncotarget ISSN: 1949-2553
Latency, duration, efficiency and quality of sleep according to socio-demographic and clinical characteristics of HDPs receiving MMT
| Characteristics | Latency (min.)# | Unstandardized Beta | Duration (hours)$ | Unstandardized Beta | Efficiency (%)$ | Unstandardized Beta | Quality# | Unstandardized Beta | |
|---|---|---|---|---|---|---|---|---|---|
| Gender | |||||||||
| Male | 412 | 38.6±38.3** | 6.737 | 8.7±2.1*** | -1.065*** | 87.0±15.2 | -1.803 | 6.7±3.6 | -0.283 |
| Female | 191 | 29.4±22.2 | Reference | 9.6±2.7 | Reference | 88.5±15.5 | Reference | 8.7±2.1 | Reference |
| Age (years) | |||||||||
| 20-39 | 327 | 36.6±28.5** | 3.722 | 9.1±2.3 | 0.623** | 87.1±14.8 | -2.271 | 6.6±3.7 | -0.216 |
| 40-59 | 276 | 34.5±40.0 | Reference | 8.8±2.4 | Reference | 87.9±16.0 | Reference | 6.7±4.0 | Reference |
| Education years | |||||||||
| <9 | 140 | 34.9±22.7 | -2.437 | 9.3±2.4 | 0.525* | 88.1±14.8 | 1.135 | 6.6±3.8 | 0.226 |
| ≥9 | 463 | 35.0±36.1 | Reference | 9.0±2.3 | Reference | 88.1±14.4 | Reference | 6.6±3.9 | Reference |
| Marital status | |||||||||
| Married | 295 | 34.4±38.4* | -1.249** | 9.1±2.5 | 0.393 | 88.7±14.0 | -0.558 | 6.4±3.7 | -0.084 |
| Non-married& | 308 | 35.6±28.1 | Reference | 9.0±2.2 | Reference | 87.5±15.0 | Reference | 6.8±4.0 | Reference |
| Employment | |||||||||
| Yes | 271 | 34.3±38.1** | -1.432* | 9.4±2.5** | 0.547* | 90.8±12.2*** | 5.355*** | 5.9±3.5*** | -1.042** |
| No | 332 | 36.7±28.7 | Reference | 8.7±2.2 | Reference | 85.6±16.2 | Reference | 7.4±4.0 | Reference |
| Self-rated economic status& | |||||||||
| Good | 149 | 34.0±42.4 | 1.023 | 8.9±2.1 | -0.412* | 91.2±13.3* | 1.022 | 5.8±3.4** | -1.386 |
| Fair | 314 | 36.8±32.4 | 1.976 | 9.1±2.4 | -0.525 | 87.0±14.5 | 0.542 | 6.8±3.7 | -2.579 |
| Poor | 140 | 33.5±24.7 | Reference | 9.2±2.4 | Reference | 86.9±15.4 | Reference | 7.1±4.6 | Reference |
| Route of heroin administration | |||||||||
| Smoking | 96 | 25.6±22.3*** | -9.849* | 9.9±2.4*** | 1.004*** | 91.7±13.7** | 2.783* | 5.6±3.7*** | -0.494** |
| Injecting | 507 | 36.8±35.0 | Reference | 8.9±2.3 | Reference | 87.4±14.6 | Reference | 6.8±3.8 | Reference |
| Duration of heroin use (years) | |||||||||
| <10 | 230 | 32.7±27.0** | -2.497* | 9.4±2.3*** | 0.347 | 89.8±12.7*** | 4.481** | 6.0±3.5*** | -1.051** |
| ≥10 | 373 | 38.5±41.5 | Reference | 8.5±2.3 | Reference | 85.3±16.6 | Reference | 7.5±4.2 | Reference |
| Duration of MMT (months) | |||||||||
| <24 | 240 | 30.0±19.5 | -2.211 | 9.2±2.2 | 0.168 | 89.2±13.8 | 1.668 | 5.9±3.4*** | -0.836** |
| ≥24 | 363 | 38.1±39.9 | Reference | 9.0±2.4 | Reference | 87.2±14.9 | Reference | 7.1±4.0 | Reference |
| Methadone dosage (mg/day) | |||||||||
| <70 | 273 | 34.2±28.3 | -0.187 | 9.0±2.1 | -0.009 | 88.6±13.4 | 0.465 | 6.2±3.5 | 0.351 |
| ≥70 | 330 | 35.6±37.2 | Reference | 9.1±2.5 | Reference | 87.7±15.3 | Reference | 6.9±4.1 | Reference |
| Depression | |||||||||
| Yes | 204 | 44.1±37.3*** | 14.612*** | 9.1±2.3 | 0.177 | 86.5±15.0* | -0.641* | 8.2±4.0*** | 2.391*** |
| No | 399 | 29.0±30.0 | Reference | 9.0±2.4 | Reference | 89.4±13.5 | Reference | 5.3±3.1 | Reference |
| Loneliness | |||||||||
| Yes | 337 | 37.4±31.9** | 10.195** | 8.8±2.3** | -0.611** | 86.3±14.7** | -3.402* | 7.4±3.9*** | 0.907** |
| No | 266 | 32.7±35.4 | Reference | 9.4±2.3 | Reference | 90.2±14.0 | Reference | 5.6±3.5 | Reference |
#Mann-Whitney U test.
$t-test.
&one-way analysis of variance.
&“Non-married” included never-married, remarried, cohabitating, separated/divorced, and widowed.
*P < 0.05, **P < 0.01, ***P < 0.001.